About Lykos Therapeutics
At Lykos Therapeutics, we are committed to making an impact on people’s lives. We envision a world where there are more tools available for the treatment of mental health and where conversations about mental health are destigmatized. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. Our initial focus is developing investigational MDMA-assisted therapy for adults living with PTSD. If approved by the FDA, MDMA-assisted therapy could be a potential new approach to treating PTSD, a condition that hasn’t had a new treatment option in decades.
MDMA-assisted therapy has been designated a Breakthrough Therapy by the FDA and the results of our two pivotal Phase 3 clinical trials were published in Nature Medicine. MDMA-assisted therapy has not been approved by any regulatory agency. The safety and efficacy of MDMA-assisted therapy have not been established for the treatment of PTSD.
Lykos is a public benefit corporation (PBC), with a dual mandate to generate shareholder value and public benefit. As a PBC, we consider the impact of our decisions on society just as we think about financial implications. We balance the interests of our many stakeholders including our employees, healthcare providers, therapists, investors and others. This means that we look through a public benefit lens with all that we do.
Why work for Lykos Therapeutics?
With 30 years of experience researching psychedelic-assisted therapies, we remain committed to the rigorous pursuit of evidence-based development of novel approaches. We value impact, integrity, care, and openness and hold public benefit at the center of everything we do. We believe in diversity and inclusion of people of all backgrounds, genders, races, ethnicities, sexual orientations, educational backgrounds, arrest or conviction record, military and veteran status, religions, abilities, and perspectives and are committed to building a supportive, equitable, and accessible workplace.
Lykos has a distributed workforce that uses technology and periodic in-person gatherings to stay connected. We look for people who believe in our mission, are comfortable with and skilled at remote work and collaboration, and ready to step into a dynamic and fast-paced work environment.
Medical Science Liaison/Senior Medical Science Liaison Executive Summary
The Medical Science Liaison (MSL) is a field-based Medical Affairs professional who serves as the scientific face between MAPS Public Benefit Corporation (MAPS PBC) and external Healthcare Professionals (HCPs). The MSL plays an important role in establishing, cultivating, and maintaining relationships with Key Opinion Leaders (KOLs) in the Post-Traumatic Stress Disorder (PTSD) and behavioral health space. The MSL is responsible for leveraging their scientific and/or therapeutic background, industry knowledge, and business acumen to conduct scientific exchange with KOLs regarding research activities, publications, education, consulting, and other Medical Affairs initiatives. Further, the MSL will provide product and pipeline therapeutic area expertise to address KOL and HCP inquiries and serve as a scientific expert to internal MAPS PBC stakeholders.
This MSL opportunity is for our Northeast region: New York & Philadelphia.
\nCompetitive benefit package includes:
Paid Time Off (PTO)
Sick Time
Holiday Pay
Medical, dental, vision, and life insurance
Employer funded mental health HRA
401k
FSA
Pet Insurance
Home Office Stipend
We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.
Click the checkbox next to the jobs that you are interested in.
Clinical Data Analysis Skill
Clinical Data Management Skill
Science Academies of NY, Frankfort, NY
AAA Northeast, Utica, NY